Author

Zhengxing Zhou

Jiangsu Province HospitalORCID 0000-0001-8507-3660Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:Hi-C· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Nan JiniD· 1 shared Ningjun DuaniD· 1 shared Wei Li· 1 shared Yijia HuaiD· 1 shared Yongmei YiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Nan JinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 28, 2026

Epigenetic and 3D Genome Changes Drive Primary Trastuzumab Resistance in HER2+ Breast Cancer

Ningjun Duan, Yijia Hua, Zhengxing Zhou…·Yongmei Yin

This study identifies epigenetic and 3D genome changes as key drivers of primary trastuzumab resistance in HER2+ breast cancer through integrative analysis of chromatin architecture and histone modifications.

DOI 10.64898/2026.04.24.720531

humanChIP-seq

𝕏 PostBluesky